Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD.
Pascual-Goñi E, Collet R, Tejada-Illa C, Martín-Aguilar L, Caballero-Ávila M, Lleixà C, Novelli S, López-Pardo J, Sanfeliu AE, Mariscal A, Álvaro Gargallo Y, Martínez-Hernández E, Cocho D, Querol L. Pascual-Goñi E, et al. Among authors: lopez pardo j. J Neurol Neurosurg Psychiatry. 2024 Jun 17;95(7):609-611. doi: 10.1136/jnnp-2023-332443. J Neurol Neurosurg Psychiatry. 2024. PMID: 38341197
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
Granell M, Senín A, Barata A, Cibeira MT, Gironella M, López-Pardo J, Motlló C, Garcia-Guiñón A, Ben-Azaiz R, Abella E, Soler A, Canet M, Martí JM, Martino R, Sierra J, de Larrea CF, Oriol A, Rosiñol L; Group for the Study of Myeloma and Amyloidosis of Catalonia (GEMMAC). Granell M, et al. Among authors: lopez pardo j. Bone Marrow Transplant. 2021 Dec;56(12):2904-2910. doi: 10.1038/s41409-021-01429-0. Epub 2021 Aug 17. Bone Marrow Transplant. 2021. PMID: 34404917
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
Jiménez-Segura R, Granell M, Gironella M, Abella E, García-Guiñón A, Oriol A, Cabezudo E, Clapés V, Soler JA, Escoda L, López-Pardo J, Fernández de Larrea C, Cibeira MT, Tovar N, Isola I, Bladé J, Rosiñol L; GEMMAC (Grup per l l'estudi del mieloma mútiple i l'amiloïdosi de Catalunya). Jiménez-Segura R, et al. Among authors: lopez pardo j. Eur J Haematol. 2019 May;102(5):389-394. doi: 10.1111/ejh.13217. Epub 2019 Feb 25. Eur J Haematol. 2019. PMID: 30719772
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.
Redondo S, García-Cadenas I, Vila A, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Arguello-Tomas M, Oñate G, López-Pardo J, Caballero AC, Miqueleiz S, Briones J, Sierra J, Sancho G, Martino R. Redondo S, et al. Among authors: lopez pardo j. Eur J Haematol. 2023 Jul;111(1):146-153. doi: 10.1111/ejh.13978. Epub 2023 Apr 14. Eur J Haematol. 2023. PMID: 37058419